BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25278686)

  • 1. Multimodality treatment of potentially curative gastric cancer: geographical variations and future prospects.
    Merrett ND
    World J Gastroenterol; 2014 Sep; 20(36):12892-9. PubMed ID: 25278686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why is neoadjuvant chemoradiation therapy underused for locally advanced rectal cancer?
    Molinari C; Passardi A
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1317-1319. PubMed ID: 27754713
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
    Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
    Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy for gastric cancer: current and future directions.
    Foo M; Leong T
    World J Gastroenterol; 2014 Oct; 20(38):13718-27. PubMed ID: 25320509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting-edge evidence of adjuvant treatments for gastric cancer.
    Shimizu D; Kanda M; Kodera Y; Sakamoto J
    Expert Rev Gastroenterol Hepatol; 2018 Nov; 12(11):1109-1122. PubMed ID: 30274536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worldwide practice in gastric cancer surgery.
    Brenkman HJ; Haverkamp L; Ruurda JP; van Hillegersberg R
    World J Gastroenterol; 2016 Apr; 22(15):4041-8. PubMed ID: 27099448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.
    Fujitani K
    Dig Surg; 2013; 30(2):119-29. PubMed ID: 23867588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for locally advanced gastric cancer.
    Aoyama T; Yoshikawa T
    Surg Today; 2017 Nov; 47(11):1295-1302. PubMed ID: 28251375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for resectable microsatellite instability-high gastric cancer?
    Lordick F
    Lancet Oncol; 2020 Feb; 21(2):203. PubMed ID: 32007193
    [No Abstract]   [Full Text] [Related]  

  • 10. Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study.
    Mokdad AA; Ali A; Yopp AC; Polanco PM; Nassour I; Mansour JC; Choti MA; Minter RM; Wang SC; Porembka MR
    Cancer; 2018 Mar; 124(6):1122-1131. PubMed ID: 29211302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.
    Kang YK; Yook JH; Park YK; Lee JS; Kim YW; Kim JY; Ryu MH; Rha SY; Chung IJ; Kim IH; Oh SC; Park YS; Son T; Jung MR; Heo MH; Kim HK; Park C; Yoo CH; Choi JH; Zang DY; Jang YJ; Sul JY; Kim JG; Kim BS; Beom SH; Cho SH; Ryu SW; Kook MC; Ryoo BY; Kim HK; Yoo MW; Lee NS; Lee SH; Kim G; Lee Y; Lee JH; Noh SH
    J Clin Oncol; 2021 Sep; 39(26):2903-2913. PubMed ID: 34133211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer.
    Slagter AE; Jansen EPM; van Laarhoven HWM; van Sandick JW; van Grieken NCT; Sikorska K; Cats A; Muller-Timmermans P; Hulshof MCCM; Boot H; Los M; Beerepoot LV; Peters FPJ; Hospers GAP; van Etten B; Hartgrink HH; van Berge Henegouwen MI; Nieuwenhuijzen GAP; van Hillegersberg R; van der Peet DL; Grabsch HI; Verheij M
    BMC Cancer; 2018 Sep; 18(1):877. PubMed ID: 30200910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital variation and the impact of postoperative complications on the use of perioperative chemo(radio)therapy in resectable gastric cancer. Results from the Dutch Upper GI Cancer Audit.
    Schouwenburg MG; Busweiler LAD; Beck N; Henneman D; Amodio S; van Berge Henegouwen MI; Cats A; van Hillegersberg R; van Sandick JW; Wijnhoven BPL; Wouters MWJ; Nieuwenhuijzen GAP;
    Eur J Surg Oncol; 2018 Apr; 44(4):532-538. PubMed ID: 29439836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.
    Knight G; Earle CC; Cosby R; Coburn N; Youssef Y; Malthaner R; Wong RK;
    Gastric Cancer; 2013 Jan; 16(1):28-40. PubMed ID: 22467061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the use of evidence-based therapy for resectable gastric cancer.
    Snyder RA; Penson DF; Ni S; Koyama T; Merchant NB
    J Surg Oncol; 2014 Sep; 110(3):285-90. PubMed ID: 24891231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards curative therapy in gastric cancer: Faraway, so close!
    Cravo M; Fidalgo C; Garrido R; Rodrigues T; Luz G; Palmela C; Santos M; Lopes F; Maio R
    World J Gastroenterol; 2015 Nov; 21(41):11609-20. PubMed ID: 26556990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond.
    Choi AH; Kim J; Chao J
    World J Gastroenterol; 2015 Jun; 21(24):7343-8. PubMed ID: 26139980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer.
    Sada YH; Smaglo BG; Tran Cao HS; Mok H; Musher BL; Massarweh NN
    J Surg Res; 2019 May; 237():41-49. PubMed ID: 30694790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal treatment of gastric cancer in the west: Where are we going?
    Marrelli D; Polom K; de Manzoni G; Morgagni P; Baiocchi GL; Roviello F
    World J Gastroenterol; 2015 Jul; 21(26):7954-69. PubMed ID: 26185368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.